113 related articles for article (PubMed ID: 5707408)
21. Effect of thyroactive materials upon plasma corticoids, pituitary prolactin, and mammary oxidative phosphorylation of lactating rats.
Sinha YN; Schmidt GH
J Dairy Sci; 1970 Aug; 53(8):1077-82. PubMed ID: 5528365
[No Abstract] [Full Text] [Related]
22. Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats.
Heuson JC; Legros N; Heimann R
Cancer Res; 1972 Feb; 32(2):233-8. PubMed ID: 5058184
[No Abstract] [Full Text] [Related]
23. Absence of modification of oestrogen receptivity in rat mammary tissue after 7,12-dimethylbenz[a]anthracene administration [proceedings].
Leclercq G; Devleeschouwer N; Deboel MC; Heuson JC
Arch Int Physiol Biochim; 1977 Feb; 85(1):181-2. PubMed ID: 68738
[No Abstract] [Full Text] [Related]
24. Effects of hypothalamic and amygdaloid lesions on development and growth of carcinogen-induced mammary tumors in the female rat.
Welsch CW; Clemens JA; Meites J
Cancer Res; 1969 Aug; 29(8):1541-9. PubMed ID: 5807229
[No Abstract] [Full Text] [Related]
25. Effect of 7-hydroxymethyl-12-methylbenz(a)anthracene on the adrenal gland of the foetal and postnatal rat.
Bird CC; Crawford AM
J Pathol; 1971 Jul; 104(3):191-9. PubMed ID: 5124978
[No Abstract] [Full Text] [Related]
26. Mechanism of induction of mammary differentiation is Sprague-Dawley female rats by perphenazine.
Ben-David M
Endocrinology; 1968 Dec; 83(6):1217-23. PubMed ID: 5721995
[No Abstract] [Full Text] [Related]
27. Effects of 4-nitroestrone 3-methyl ether on dimethylbenz(a)anthracene-induced mammary tumors.
Rozhin J; Ludwig EH; Corombos J; Odden D; Horwitz JP; Hughes R; Hughes DE; Wilson E; Brooks SC
Cancer Res; 1983 Jun; 43(6):2611-7. PubMed ID: 6406049
[TBL] [Abstract][Full Text] [Related]
28. [On the adrenocorticolytic action of 7, 12-dimethylbenz (alpha) anthracene in rats. Can gonad function influence adrenal susceptibility to toxic agents?].
Colafranceschi M; Tosi P
Arch De Vecchi Anat Patol; 1967 Aug; 49(2):541-64. PubMed ID: 5608912
[No Abstract] [Full Text] [Related]
29. Inhibitory effect of actinomycin D on the inductio of rat mammary tumors by in vitro exposure to 7,12-dimethylbenz(a)anthracene.
Tominaga T; Tei N; Taguchi T; Takeda Y
Cancer Res; 1975 Jul; 35(7):1698-701. PubMed ID: 805663
[TBL] [Abstract][Full Text] [Related]
30. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.
Yanai R; Nagasawa H
J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649
[No Abstract] [Full Text] [Related]
31. Endocrine differences between rats bearing simple and malignant mammary tumours induced by 9,10-dimethyl-1,2-benzanthracene.
Hamilton T; Sneddon A
Br J Cancer; 1968 Jun; 22(2):324-9. PubMed ID: 5660137
[No Abstract] [Full Text] [Related]
32. Transplantable myeloid rat leukaemia induced by 7,12-dimethylbenz(a)anthracene.
Gál F; Somfai S; Szentirmay Z
Acta Haematol; 1973; 49(5):281-90. PubMed ID: 4198909
[No Abstract] [Full Text] [Related]
33. Effect of a carcinogenic oral dose of 7, 12-dimethylbenz(a)anthracene on receptor binding of estradiol-17 beta in uterus and mammary tissue throughout lactation in the rat.
Keightley DD; Okey AB
Cancer Res; 1974 Mar; 34(3):609-12. PubMed ID: 4359882
[No Abstract] [Full Text] [Related]
34. Comparative biologic activities of 7,12-dimethylbenz(a)anthracene, 7-hydroxymethyl-12-methylbenz(a)anthracene, 7,12-dehydroxy-methylbenz(a)anthracene, and 4-methoxy-7,12-dimethylbenz(a)anthracene in the Sprague-Dawley female rat.
Sydnor KL; Flesher JW
Cancer Res; 1969 Feb; 29(2):403-8. PubMed ID: 5765420
[No Abstract] [Full Text] [Related]
35. Inhibition by hypothalamic prolactin implants of prolactin secretion, mammary growth and luteal function.
Clemens JA; Meites J
Endocrinology; 1968 Apr; 82(4):878-81. PubMed ID: 5742204
[No Abstract] [Full Text] [Related]
36. Physiological conditions for the secretion of prolactin from the anterior pituitary.
Gachev EP
Endokrinologie; 1968; 53(5):352-4. PubMed ID: 5753127
[No Abstract] [Full Text] [Related]
37. [Proceedings: Physiological aspects of prolactin secretion during lactation].
Mena F; Grosvenor CE
Acta Physiol Lat Am; 1973; 23(6):490-1. PubMed ID: 4800120
[No Abstract] [Full Text] [Related]
38. Effects of hypothyroidism and progesterone on mammary tumours induced by 7,12-dimethylbenz(a)anthracene in Sprague-Dawley rats.
Jabara AG; Maritz JS
Br J Cancer; 1973 Aug; 28(2):161-72. PubMed ID: 4738218
[TBL] [Abstract][Full Text] [Related]
39. Hyperplastic lesions in the mammary glands of Sprague-Dawley rats after 7,12-dimethyl-benz[a]anthracene treatment.
Beuving LJ; Faulkin LJ; DeOme KB; Bergs VV
J Natl Cancer Inst; 1967 Sep; 39(3):423-9. PubMed ID: 6047995
[No Abstract] [Full Text] [Related]
40. Comparative effects of hypophysectomy, ergocornine and ergocornine-reserpine treatments on rat mammary carcinoma.
Welsch CW; Iturri G; Meites J
Int J Cancer; 1973 Jul; 12(1):206-12. PubMed ID: 4790704
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]